Just a reminder: Ebola-chan was born 9 weeks after the start of the last vaccination trial.
>Cincinnati Children's Hospital is starting a clinical trial of vaccines against Ebola.
>The study is sponsored by the National Institute of Allergy and Infectious Diseases,
>part of the National Institutes of Health.
>Cincinnati Children's is one of nine funded vaccine and treatment evaluation units.
>The trial will test two experimental vaccines together for their safety and ability to
>produce an immune response in healthy volunteer participants.
>This study will enroll up to 60 volunteers 18 to 45 years old, who will be monitored
>closely for adverse events for six months after initial vaccination during at least 12
>clinic visits.
>During the clinic visits, the volunteers will get blood tests to assess potential immune
>responses to both experimental vaccines. Each volunteer will participate in the trial
>for about seven months.
>"Researchers are looking for new ways to stop these outbreaks and to treat people
>who become infected and develop Ebola virus disease. The development of
>preventive vaccines for Ebola is a top global public health priority," said lead trial
>investigator Paul Spearman, MD.
>An outbreak in the Democratic Republic of Congo includes more than 700
>confirmed and probable Ebola cases
https://www.beckershospitalreview.com/quality/cincinnatPost too long. Click here to view the full text.